$MRNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Moderna, Inc.. Get notifications about new insider transactions in Moderna, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 166.31 | 700 | 116,417 | 100 | 800 to 100 (-87.50 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 165.04 | 462 | 76,248 | 800 | 1.3 K to 800 (-36.61 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 163.89 | 500 | 81,945 | 1,262 | 1.8 K to 1.3 K (-28.38 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 162.65 | 1,250 | 203,313 | 1,762 | 3 K to 1.8 K (-41.50 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 161.62 | 1,332 | 215,278 | 3,012 | 4.3 K to 3 K (-30.66 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 160.48 | 656 | 105,275 | 4,344 | 5 K to 4.3 K (-13.12 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 171.42 | 530 | 90,853 | 66,292 | 66.8 K to 66.3 K (-0.79 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 170.42 | 2,938 | 500,694 | 66,822 | 69.8 K to 66.8 K (-4.21 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 169.42 | 1,017 | 172,300 | 69,760 | 70.8 K to 69.8 K (-1.44 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 168.42 | 500 | 84,210 | 70,777 | 71.3 K to 70.8 K (-0.70 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 167.18 | 1,100 | 183,898 | 71,277 | 72.4 K to 71.3 K (-1.52 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 166.24 | 1,131 | 188,017 | 72,377 | 73.5 K to 72.4 K (-1.54 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 164.48 | 100 | 16,448 | 73,508 | 73.6 K to 73.5 K (-0.14 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 163.50 | 500 | 81,750 | 73,608 | 74.1 K to 73.6 K (-0.67 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 162.38 | 600 | 97,428 | 74,108 | 74.7 K to 74.1 K (-0.80 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 161.59 | 1,530 | 247,233 | 74,708 | 76.2 K to 74.7 K (-2.01 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 160.18 | 700 | 112,126 | 76,238 | 76.9 K to 76.2 K (-0.91 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 158.84 | 400 | 63,536 | 76,938 | 77.3 K to 76.9 K (-0.52 %) |
Apr 16 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 158.76 | 10,000 | 1,587,600 | 7,454,880 | 7.5 M to 7.5 M (-0.13 %) |
Apr 16 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,356,868 | 6.4 M to 6.4 M (-0.03 %) |
Apr 16 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 153.75 | 9,000 | 1,383,750 | 6,358,868 | 6.4 M to 6.4 M (-0.14 %) |
Apr 16 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 574,822 | |
Apr 16 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 153.75 | 5,000 | 768,750 | 0 | 5 K to 0 (-100.00 %) |
Apr 16 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 14 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 139,676 | |
Apr 14 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 146.62 | 6,600 | 967,692 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 527,431 | |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 336,972 | |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 341,972 | |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 146.62 | 15,000 | 2,199,300 | 1,609,597 | 1.6 M to 1.6 M (-0.92 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,624,597 | 1.6 M to 1.6 M (+0.62 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 142.46 | 5,000 | 712,300 | 1,609,597 | 1.6 M to 1.6 M (-0.31 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 156,282 | |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 143.09 | 100 | 14,309 | 0 | 100 to 0 (-100.00 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 141.79 | 400 | 56,716 | 100 | 500 to 100 (-80.00 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 140.22 | 413 | 57,911 | 500 | 913 to 500 (-45.24 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 139.38 | 1,824 | 254,229 | 913 | 2.7 K to 913 (-66.64 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 138.06 | 1,400 | 193,284 | 2,737 | 4.1 K to 2.7 K (-33.84 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 137.16 | 863 | 118,369 | 4,137 | 5 K to 4.1 K (-17.26 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 13 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 579,822 | |
Apr 13 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 142.46 | 5,000 | 712,300 | 0 | 5 K to 0 (-100.00 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 143.06 | 1,968 | 281,542 | 77,338 | 79.3 K to 77.3 K (-2.48 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 142.31 | 2,603 | 370,433 | 79,306 | 81.9 K to 79.3 K (-3.18 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 141.25 | 4,143 | 585,199 | 81,909 | 86.1 K to 81.9 K (-4.81 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 139.85 | 400 | 55,940 | 86,052 | 86.5 K to 86.1 K (-0.46 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 137.40 | 400 | 54,960 | 86,452 | 86.9 K to 86.5 K (-0.46 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 136.54 | 1,232 | 168,217 | 86,852 | 88.1 K to 86.9 K (-1.40 %) |
Apr 13 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.97 | 300 | 40,191 | 88,084 | 88.4 K to 88.1 K (-0.34 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 146,276 | |
Apr 09 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 132.85 | 6,600 | 876,810 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.85 | 10,000 | 1,328,500 | 7,464,880 | 7.5 M to 7.5 M (-0.13 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,367,868 | 6.4 M to 6.4 M (-0.03 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 131.63 | 9,000 | 1,184,670 | 6,369,868 | 6.4 M to 6.4 M (-0.14 %) |
Apr 08 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 584,822 | |
Apr 08 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 131.63 | 5,000 | 658,150 | 0 | 5 K to 0 (-100.00 %) |
Apr 08 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 08 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 152,876 | |
Apr 08 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 130.01 | 6,600 | 858,066 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 08 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 161,282 | |
Apr 06 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 130.95 | 1,150 | 150,593 | 0 | 1.2 K to 0 (-100.00 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 129.96 | 2,426 | 315,283 | 2,574 | 5 K to 2.6 K (-48.52 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 128.65 | 814 | 104,721 | 1,150 | 2 K to 1.2 K (-41.45 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 127.76 | 610 | 77,934 | 1,964 | 2.6 K to 2 K (-23.70 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 06 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 589,822 | |
Apr 06 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 132.63 | 5,000 | 663,150 | 0 | 5 K to 0 (-100.00 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 06 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 537,431 | |
Apr 06 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 547,431 | |
Apr 06 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 132.63 | 20,000 | 2,652,600 | 1,609,597 | 1.6 M to 1.6 M (-1.23 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,629,597 | 1.6 M to 1.6 M (+0.62 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,619,597 | 1.6 M to 1.6 M (+0.62 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.73 | 100 | 13,273 | 88,384 | 88.5 K to 88.4 K (-0.11 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.97 | 2,533 | 331,747 | 88,484 | 91 K to 88.5 K (-2.78 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.00 | 5,157 | 670,410 | 91,017 | 96.2 K to 91 K (-5.36 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.72 | 2,131 | 274,302 | 96,174 | 98.3 K to 96.2 K (-2.17 %) |
Apr 06 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 127.72 | 1,125 | 143,685 | 98,305 | 99.4 K to 98.3 K (-1.13 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.51 | 10,000 | 1,325,100 | 7,474,880 | 7.5 M to 7.5 M (-0.13 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,378,868 | 6.4 M to 6.4 M (-0.03 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 121.10 | 9,000 | 1,089,900 | 6,380,868 | 6.4 M to 6.4 M (-0.14 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 159,476 | |
Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 132.51 | 6,600 | 874,566 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 166,076 | |
Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 123.30 | 6,600 | 813,780 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 01 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 594,822 | |
Apr 01 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 121.10 | 5,000 | 605,500 | 0 | 5 K to 0 (-100.00 %) |
Apr 01 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.07 | 4,888 | 591,810 | 9,116,657 | 9.1 M to 9.1 M (-0.05 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.44 | 1,000 | 123,440 | 9,121,545 | 9.1 M to 9.1 M (-0.01 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.08 | 31,943 | 3,931,538 | 9,122,545 | 9.2 M to 9.1 M (-0.35 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.71 | 14,379 | 1,750,038 | 9,154,488 | 9.2 M to 9.2 M (-0.16 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 120.76 | 225,732 | 27,259,283 | 9,168,867 | 9.4 M to 9.2 M (-2.40 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 119.81 | 344,542 | 41,278,061 | 9,394,599 | 9.7 M to 9.4 M (-3.54 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.90 | 611,922 | 72,758,505 | 9,739,141 | 10.4 M to 9.7 M (-5.91 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.04 | 883,277 | 104,265,815 | 10,351,063 | 11.2 M to 10.4 M (-7.86 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 131.30 | 558 | 73,265 | 11,234,340 | 11.2 M to 11.2 M (0.00 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 130.56 | 6,610 | 862,994 | 11,234,898 | 11.2 M to 11.2 M (-0.06 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 129.54 | 83,242 | 10,783,377 | 11,241,508 | 11.3 M to 11.2 M (-0.74 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 128.74 | 123,374 | 15,883,527 | 11,324,750 | 11.4 M to 11.3 M (-1.08 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 127.47 | 46,872 | 5,974,788 | 11,448,124 | 11.5 M to 11.4 M (-0.41 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 126.40 | 82,557 | 10,434,924 | 11,494,996 | 11.6 M to 11.5 M (-0.71 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 125.36 | 116,383 | 14,589,226 | 11,577,553 | 11.7 M to 11.6 M (-1.00 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 124.42 | 251,545 | 31,296,927 | 11,693,936 | 11.9 M to 11.7 M (-2.11 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.50 | 639,681 | 78,998,365 | 11,945,481 | 12.6 M to 11.9 M (-5.08 %) |
Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 122.54 | 284,300 | 34,836,672 | 12,585,162 | 12.9 M to 12.6 M (-2.21 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.72 | 500 | 67,360 | 99,430 | 99.9 K to 99.4 K (-0.50 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.10 | 3,200 | 429,120 | 99,930 | 103.1 K to 99.9 K (-3.10 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.06 | 3,006 | 399,978 | 103,130 | 106.1 K to 103.1 K (-2.83 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.04 | 2,915 | 384,897 | 106,136 | 109.1 K to 106.1 K (-2.67 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.73 | 700 | 91,511 | 109,051 | 109.8 K to 109.1 K (-0.64 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 129.40 | 300 | 38,820 | 109,751 | 110.1 K to 109.8 K (-0.27 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.89 | 425 | 54,778 | 110,051 | 110.5 K to 110.1 K (-0.38 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 599,822 | |
Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 130.05 | 5,000 | 650,250 | 0 | 5 K to 0 (-100.00 %) |
Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 126.88 | 10,000 | 1,268,800 | 7,484,880 | 7.5 M to 7.5 M (-0.13 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,389,868 | 6.4 M to 6.4 M (-0.03 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 137.07 | 9,000 | 1,233,630 | 6,391,868 | 6.4 M to 6.4 M (-0.14 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 172,676 | |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 126.88 | 6,600 | 837,408 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 346,972 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 351,972 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 557,431 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 137.07 | 5,000 | 685,350 | 1,609,597 | 1.6 M to 1.6 M (-0.31 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 145.50 | 5,800 | 843,900 | 1,609,597 | 1.6 M to 1.6 M (-0.36 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 144.19 | 286 | 41,238 | 1,615,397 | 1.6 M to 1.6 M (-0.02 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 143.44 | 600 | 86,064 | 1,615,683 | 1.6 M to 1.6 M (-0.04 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 141.98 | 859 | 121,961 | 1,616,283 | 1.6 M to 1.6 M (-0.05 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 141.22 | 1,100 | 155,342 | 1,617,142 | 1.6 M to 1.6 M (-0.07 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 140.16 | 1,702 | 238,552 | 1,618,242 | 1.6 M to 1.6 M (-0.11 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 139.19 | 1,873 | 260,703 | 1,619,944 | 1.6 M to 1.6 M (-0.12 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 138.25 | 2,139 | 295,717 | 1,621,817 | 1.6 M to 1.6 M (-0.13 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 136.96 | 641 | 87,791 | 1,623,956 | 1.6 M to 1.6 M (-0.04 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,624,597 | 1.6 M to 1.6 M (+0.62 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 604,822 | |
Mar 25 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 137.07 | 5,000 | 685,350 | 0 | 5 K to 0 (-100.00 %) |
Mar 25 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |